559 related articles for article (PubMed ID: 19818304)
21. Diabetes and apoptosis: lipotoxicity.
Kusminski CM; Shetty S; Orci L; Unger RH; Scherer PE
Apoptosis; 2009 Dec; 14(12):1484-95. PubMed ID: 19421860
[TBL] [Abstract][Full Text] [Related]
22. Ceramides in insulin resistance and lipotoxicity.
Summers SA
Prog Lipid Res; 2006 Jan; 45(1):42-72. PubMed ID: 16445986
[TBL] [Abstract][Full Text] [Related]
23. Molecular determinants of insulin resistance, cell apoptosis and lipid accumulation in non-alcoholic steatohepatitis.
Piro S; Spadaro L; Russello M; Spampinato D; Oliveri CE; Vasquez E; Benigno R; Brancato F; Purrello F; Rabuazzo AM
Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):545-52. PubMed ID: 18063353
[TBL] [Abstract][Full Text] [Related]
24. Impact of visceral adipose tissue on liver metabolism and insulin resistance. Part II: Visceral adipose tissue production and liver metabolism.
Girard J; Lafontan M
Diabetes Metab; 2008 Nov; 34(5):439-45. PubMed ID: 18562233
[TBL] [Abstract][Full Text] [Related]
25. Deleterious action of FA metabolites on ATP synthesis: possible link between lipotoxicity, mitochondrial dysfunction, and insulin resistance.
Abdul-Ghani MA; Muller FL; Liu Y; Chavez AO; Balas B; Zuo P; Chang Z; Tripathy D; Jani R; Molina-Carrion M; Monroy A; Folli F; Van Remmen H; DeFronzo RA
Am J Physiol Endocrinol Metab; 2008 Sep; 295(3):E678-85. PubMed ID: 18593850
[TBL] [Abstract][Full Text] [Related]
26. [Insulin resistance].
Tamura Y; Kawamori R
Nihon Rinsho; 2006 Jun; 64(6):1071-4. PubMed ID: 16768111
[TBL] [Abstract][Full Text] [Related]
27. [Diagnosis and therapy in NASH].
Tokushige K
Rinsho Byori; 2009 Sep; 57(9):848-53. PubMed ID: 19860210
[TBL] [Abstract][Full Text] [Related]
28. Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease.
Videla LA; Rodrigo R; Araya J; Poniachik J
Free Radic Biol Med; 2004 Nov; 37(9):1499-507. PubMed ID: 15454290
[TBL] [Abstract][Full Text] [Related]
29. Lipid peroxidation is not a prerequisite for the development of obesity and diabetes in high-fat-fed mice.
Sohet FM; Neyrinck AM; Dewulf EM; Bindels LB; Portois L; Malaisse WJ; Carpentier YA; Cani PD; Delzenne NM
Br J Nutr; 2009 Aug; 102(3):462-9. PubMed ID: 19161640
[TBL] [Abstract][Full Text] [Related]
30. [Role of lipid peroxidation in non-alcoholic steatohepatitis].
Fraenkel E; Lazúrová I; Fehér J
Orv Hetil; 2004 Mar; 145(12):611-8. PubMed ID: 15119115
[TBL] [Abstract][Full Text] [Related]
31. Abnormalities of lipid metabolism in nonalcoholic fatty liver disease.
Cheung O; Sanyal AJ
Semin Liver Dis; 2008 Nov; 28(4):351-9. PubMed ID: 18956291
[TBL] [Abstract][Full Text] [Related]
32. Impact of non-alcoholic fatty liver disease on accelerated metabolic complications.
Fan JG
J Dig Dis; 2008 May; 9(2):63-7. PubMed ID: 18419637
[TBL] [Abstract][Full Text] [Related]
33. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites.
Neuschwander-Tetri BA
Hepatology; 2010 Aug; 52(2):774-88. PubMed ID: 20683968
[TBL] [Abstract][Full Text] [Related]
34. Environmental and genetic determinants of fatty liver in humans.
Kantartzis K; Schick F; Häring HU; Stefan N
Dig Dis; 2010; 28(1):169-78. PubMed ID: 20460907
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms of obesity-associated insulin resistance: many choices on the menu.
Qatanani M; Lazar MA
Genes Dev; 2007 Jun; 21(12):1443-55. PubMed ID: 17575046
[TBL] [Abstract][Full Text] [Related]
36. Decrease of eicosapentaenoic acid in fatty liver of diabetic subjects.
Singer P; Honigmann G; Schliack V
Prostaglandins Med; 1980 Sep; 5(3):183-200. PubMed ID: 6251498
[TBL] [Abstract][Full Text] [Related]
37. Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease.
Koliaki C; Roden M
Mol Cell Endocrinol; 2013 Oct; 379(1-2):35-42. PubMed ID: 23770462
[TBL] [Abstract][Full Text] [Related]
38. Molecular mechanisms of lipid-induced insulin resistance in muscle, liver and vasculature.
Krebs M; Roden M
Diabetes Obes Metab; 2005 Nov; 7(6):621-32. PubMed ID: 16219006
[TBL] [Abstract][Full Text] [Related]
39. Non-alcoholic steatohepatitis: review of a growing medical problem.
Te Sligte K; Bourass I; Sels JP; Driessen A; Stockbrugger RW; Koek GH
Eur J Intern Med; 2004 Feb; 15(1):10-21. PubMed ID: 15066643
[TBL] [Abstract][Full Text] [Related]
40. Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis.
Marra F; Gastaldelli A; Svegliati Baroni G; Tell G; Tiribelli C
Trends Mol Med; 2008 Feb; 14(2):72-81. PubMed ID: 18218340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
